Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DDD (officially D.D.D. Limited) was a family-owned UK-based healthcare, beauty, and pharmaceutical manufacturer and distributor founded in 1912 and headquartered in Watford. The company developed, manufactured, and distributed its own portfolio of well-known consumer brands, including Astral, Dentinox, Snufflebabe, and Ibuleve, while also providing contract manufacturing and development services (CDMO/CMO) to third-party clients. In February 2020, DDD entered administration due to financial difficulties, and its business and assets were subsequently sold to Dendron Brands Limited, a subsidiary of Phoenix Labs. The original corporate entity was subsequently liquidated.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DDD.